Access cutting-edge intestinal failure treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access intestinal failure specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related intestinal failure treatment provided free
This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NST-6179 in subjects with intestinal failure-associated liver disease (IFALD) receiving parenteral nutrition (PN). The study will be conducted in 2 sequential parts. Up to 36 subjects diagnosed with IFALD will be enrolled in the study, of which up to 18 subjects will be enrolled in each of the 2 parts and randomized (2:1) t
Sponsor: NorthSea Therapeutics B.V.
Check if you qualify for this intestinal failure clinical trial in Washington Dc, DC
If you're searching for intestinal failure treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced intestinal failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.